Institut Laue-Langevin

What Institut Laue-Langevin does

Institut Laue-Langevin (ILL) is an international research centre headquartered in Grenoble, France, founded in 1967 and operated as a consortium-funded intergovernmental facility by 13 scientific member countries: France, Germany, the United Kingdom, Austria, Denmark, Czech Republic, Italy, Poland, Slovakia, Slovenia, Spain, Sweden, and Switzerland. ILL operates the world's most intense continuous-wave neutron source, a high-flux research reactor, and provides scientists with access to a comprehensive suite of neutron scattering instruments including diffractometers (D1B–D33), spectrometers (IN series), reflectometers (FIGARO, SuperADAM), and imaging instruments (NeXT, LADI-III), supported by advanced sample environments (cryogenics, high pressure, high magnetic field) and scientific software (Mantid, GRASP, Int3D, Takin, SXtalSoft, Mag2Pol).

ILL's core commercial activity is the allocation of beamtime to researchers from member countries through a merit-based proposal system, serving use cases in condensed matter physics, chemistry, materials science, magnetism and quantum materials, soft matter and biology, and nuclear and particle physics. Beyond academic beamtime, ILL has productized dedicated science hubs such as the Neutron Battery Hub for energy storage research, and produces medical radioisotopes (notably Lutetium-177) via partnerships such as the June 2024 agreement with Curium for non-carrier-added Lu-177 supply to the radiopharmaceutical market. The ILL Graduate School (IGS) sustains 40-60 active PhD projects with ~15 new entrants per year, anchoring the talent pipeline and academic engagement across Europe.

ILL is a government-state entity, not a for-profit enterprise; its revenue mechanics are anchored in member-country contributions supplemented by industrial partnerships, EU programme funding (e.g., the 1.4 M€ ASCENT award under "Choose Europe for Science 2025"), and applied research collaborations. Leadership is transitioning, with Regine Willumeit-Römer set to become Director on 1 October 2026 alongside continuing Associate Directors Ken Andersen and Jacques Jestin, signalling an upcoming strategy refresh aligned with the Science Strategy 2025.

Name

Institut Laue-Langevin

Legal name

Institut Laue-Langevin

Website

https://www.ill.eu

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Institut Laue-Langevin is an international research center at the leading edge of neutron science and technology.

Ownership category

akta.pro rank

Product category

Scientific Research Facility

NAICS

Nuclear Electric Power Generation (221113), Irradiation Apparatus Manufacturing (334517)

SIC

Laboratory Analytical Instruments (3826), Industrial Instruments For Measurement, Display, And Control (3823)

akta.pro primary industry

Research & Test Reactor Operations (Non-Commercial Power) (EUACADAH)

akta.pro secondary industries

Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD), In-Core & Ex-Core Instrumentation (Neutron Flux, Temperature, Pressure, Vibration) (EUAKADAL)

Keywords

• Neutron scattering research
• Scientific research facility
• Neutron beam source
• Materials science research
• International research center

Headquarters

HQ city

Grenoble

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Others

Distribution channels3 records

Marketing channels5 records

Core offering

Institut Laue-Langevin operates the world's most intense neutron source, providing external researchers and industrial users with allocated beam time on a large fleet of neutron scattering instruments. The institute delivers experimental support, sample environment capabilities, and scientific expertise across disciplines including condensed-matter physics, chemistry, biology, materials science, and engineering, with the reactor and instrument suite physically located in Grenoble, France.

Product overview

The Institut Laue-Langevin (ILL) operates the world's most intense neutron source—a high-flux research reactor in Grenoble, France—and provides scientists with access to this facility through beam time allocations. The ILL offers a comprehensive suite of neutron scattering instruments including diffractometers (D1B-D33), spectrometers (IN series), reflectometers (D17, FIGARO, SuperADAM), and imaging instruments (NeXT, LADI-III), alongside polarized beam capabilities. The facility supports research across materials science, biology, chemistry, magnetism, and quantum materials. Beyond core beam access, ILL provides the ILL Graduate School (IGS) for PhD training, sample environment equipment, sample preparation labs, scientific software tools (Mantid, GRASP), and medical radioisotope production. The institution functions as an international research facility serving scientists from member countries (France, Germany, UK, Austria, Denmark, Czech Republic, Italy, Poland, Slovakia, Slovenia, Spain, Sweden, Switzerland) through a beamtime proposal system.

Differentiator

Problem solved

Functional benefit

Brands

• ILL Graduate School (IGS): Graduate school program coordinating PhD research at ILL

Products and services

• Academic Beam Time Access Peer-reviewed allocation of neutron beam time on ILL's scientific instruments for university and public-research users conducting fundamental and applied research in physics, chemistry, biology, and materials science.
• Industrial Partnership Programme Confidential, paid beam-time service for industrial R&D teams in pharmaceuticals, energy, aerospace, and advanced materials, providing neutron characterisation with full data ownership and proprietary handling.
• Scientific Training and User Programmes On-site training, PhD and postdoctoral programmes, and user schools that develop expertise in neutron scattering techniques among the next generation of scientists.

Quantifiable outcome

• Enables real-time tracking of lithium-ion movement in solid-state batteries, providing insights for optimizing battery design for electric vehicles
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• CuriumcoreStrategic or Co-development Partner · 1 June 2024Curium partnered with Institut Laue-Langevin in June 2024 to expand non-carrier-added Lutetium-177 (Lu-177) production. Lu-177 is a critical medical isotope used in precision radiopharmaceutical therapies for cancer treatment, including drugs like Lutathera and Pluvicto. This partnership enhances supply chain capabilities for radiopharmaceutical therapies.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• European Spallation Source (ESS): ESS in Lund, Sweden, operates a next-generation pulsed spallation neutron source under construction, designed to become the world's most powerful linear proton accelerator-based neutron facility. Direct peer to ILL as a pan-European neutron science user facility serving similar academic and industrial research communities.
• ISIS Neutron and Muon Source: ISIS at the Rutherford Appleton Laboratory (UK) operates a pulsed spallation neutron and muon source. Direct peer as another major European neutron user facility, offering complementary techniques (muons, spallation-based) to ILL's reactor-based continuous wave source.
• Spallation Neutron Source (SNS) at Oak Ridge National Laboratory: SNS at Oak Ridge is the most powerful pulsed spallation neutron source in the world. Direct peer to ILL as a leading neutron scattering user facility, serving comparable condensed matter, materials science, and biology research communities.
• FRM II / Heinz Maier-Leibnitz Zentrum (MLZ): FRM II is a high-flux research reactor in Garching, Germany, operated jointly with MLZ as a neutron scattering user facility. Direct peer operating a comparable reactor-based neutron source, and notably a co-funding partner within the broader European neutron ecosystem alongside ILL.
• J-PARC (Japan Proton Accelerator Research Complex): J-PARC is Japan's leading accelerator-based multi-disciplinary research facility, housing the Materials and Life Science Experimental Facility with pulsed neutron and muon sources. Direct peer as a major neutron user facility serving materials science, condensed matter physics, and industrial research.

Regional players

• European Synchrotron Radiation Facility (ESRF): ESRF in Grenoble operates the world's most intense hard X-ray synchrotron source for materials characterization. Regional peer co-located in Grenoble with ILL, offering complementary photon-based techniques to ILL's neutron scattering for the same scientific user community.

Others

• Curium: Curium is ILL's strategic partner for Lu-177 radiopharmaceutical production. Comparable as a downstream participant in the nuclear medicine supply chain that depends on ILL's reactor-produced isotopes for its cancer therapy portfolio.

Broad incumbents

• Helmholtz-Zentrum Berlin (HZB): HZB operates the BER II research reactor (now in decommissioning) and the BESSY II synchrotron in Germany, providing neutron and X-ray user facilities. Broad incumbent as a German national lab with overlapping neutron scattering capabilities and a major ILL member-country stakeholder.
• Paul Scherrer Institut (PSI): PSI operates the SINQ spallation neutron source and Swiss Light Source synchrotron, alongside proton therapy. Broad incumbent as a Swiss national multi-disciplinary research facility with neutron scattering capabilities comparable to ILL's, and an ILL member-country institution.
• CERN: CERN operates the Large Hadron Collider and complex particle accelerators for fundamental physics research. Broad incumbent as a major European intergovernmental research organization operating large-scale scientific infrastructure under a similar multi-country consortium model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ILLGrenoble
• YouTubeyoutube.com/c/InstitutLaueLangevin
• LinkedInlinkedin.com/company/institut-laue-langevin
• Instagraminstagram.com/ill_neutrons_for_society
• Facebookfacebook.com/ILLGrenoble

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Laue-Langevin